Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12607000179437
Ethics application status
Approved
Date submitted
19/03/2007
Date registered
22/03/2007
Date last updated
22/03/2007
Type of registration
Retrospectively registered
Titles & IDs
Public title
The effect of atorvastatin on lung function and morbidity as add-on therapy in asthmatic patients. A double-blind randomized cross-over trial.
Query!
Scientific title
The effect of atorvastatin on lung function and morbidity as add-on therapy in normolipid asthmatic patients. A double-blind placebo controlled randomized cross-over trial.
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Moderate to severe persistent asthma
1697
0
Query!
Condition category
Condition code
Respiratory
1789
1789
0
0
Query!
Asthma
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
atorvastatin 10 mg per day oral for one month or placebo oral for one month, each therapy separated with 2 weeks wash out period (cross-over)
Query!
Intervention code [1]
1657
0
Treatment: Drugs
Query!
Comparator / control treatment
Placebo oral for one month,
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
2504
0
Changes in Forced Expiratory Volume in one second (FEV1)
Query!
Assessment method [1]
2504
0
Query!
Timepoint [1]
2504
0
At baseline and after 4 weeks of each intervention (placebo or atorvastatin therapy)
Query!
Primary outcome [2]
2505
0
Changes in Forced Vital Capacity (FVC)
Query!
Assessment method [2]
2505
0
Query!
Timepoint [2]
2505
0
At baseline and after 4 weeks of each intervention (placebo or atorvastatin therapy)
Query!
Primary outcome [3]
2506
0
Changes in Peak Expiratory Flow (PEF)
Query!
Assessment method [3]
2506
0
Query!
Timepoint [3]
2506
0
At baseline and after 4 weeks of each intervention (placebo or atorvastatin therapy)
Query!
Secondary outcome [1]
4318
0
Changes in score of Jones Index of Morbidity
Query!
Assessment method [1]
4318
0
Query!
Timepoint [1]
4318
0
At baseline and after 4 weeks of each intervention (placebo or atorvastatin therapy).
Query!
Eligibility
Key inclusion criteria
Persistent moderate to severe asthma
Query!
Minimum age
16
Years
Query!
Query!
Maximum age
65
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Dyslipidemia, adverse effect due to atorvastatin, other comorbid condition (heart failure, diabetes, MI, hypertension), receiving medication(s) interact with atorvastatin.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
allocation concealed by sealed opaque envelopes
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation by using a randomisation table from a statistic book
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Crossover
Query!
Other design features
the people receiving the treatment/s (subjects), the clinician administering the treatment/s, the researcher assessing the outcomes are blinded in the study
Query!
Phase
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
20/10/2006
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
17
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
493
0
Iran, Islamic Republic Of
Query!
State/province [1]
493
0
Query!
Funding & Sponsors
Funding source category [1]
1940
0
Government body
Query!
Name [1]
1940
0
National Research Institute of Tuberculosis and Lung Disease
Query!
Address [1]
1940
0
Query!
Country [1]
1940
0
Iran, Islamic Republic Of
Query!
Primary sponsor type
University
Query!
Name
Shaheed Beheshti University of Medical Sciences, Iran
Query!
Address
Query!
Country
Iran, Islamic Republic Of
Query!
Secondary sponsor category [1]
1751
0
Hospital
Query!
Name [1]
1751
0
Masih Daneshvari Hospital, Iran
Query!
Address [1]
1751
0
Query!
Country [1]
1751
0
Iran, Islamic Republic Of
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
3618
0
Masih Daneshvari Hospital, NRITLD
Query!
Ethics committee address [1]
3618
0
Query!
Ethics committee country [1]
3618
0
Iran, Islamic Republic Of
Query!
Date submitted for ethics approval [1]
3618
0
Query!
Approval date [1]
3618
0
20/10/2006
Query!
Ethics approval number [1]
3618
0
500
Query!
Summary
Brief summary
The main goal of the study was to assess the effects of atorvastatin on asthma as an inflammatory disease.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
27760
0
Query!
Address
27760
0
Query!
Country
27760
0
Query!
Phone
27760
0
Query!
Fax
27760
0
Query!
Email
27760
0
Query!
Contact person for public queries
Name
10846
0
Fanak Fahimi
Query!
Address
10846
0
Masih Daneshvari Hospital, Shaheed Bahonar Ave, Darabad,
TEHRAN 19569, P.O: 19575/154
Query!
Country
10846
0
Iran, Islamic Republic Of
Query!
Phone
10846
0
+98 912 1940902
Query!
Fax
10846
0
+98 21 22678090
Query!
Email
10846
0
[email protected]
Query!
Contact person for scientific queries
Name
1774
0
Fanak Fahimi
Query!
Address
1774
0
Masih Daneshvari Hospital
Shaheed Bahonar Ave
Darabad
Tehran 19569
P.O: 19575/154
Query!
Country
1774
0
Iran, Islamic Republic Of
Query!
Phone
1774
0
+98 912 1940902
Query!
Fax
1774
0
Query!
Email
1774
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF